The Beauty Health Company (NASDAQ:SKIN) Given Consensus Rating of “Reduce” by Brokerages

The Beauty Health Company (NASDAQ:SKIN) has received an average recommendation of “Reduce” from the eleven analysts that are covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has issued a buy rating on the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $2.46.

A number of research firms recently commented on SKIN. Canaccord Genuity Group dropped their price objective on Beauty Health from $2.00 to $1.25 and set a “hold” rating for the company in a report on Monday, August 12th. Piper Sandler reaffirmed an “underweight” rating and issued a $1.00 price target (down from $1.50) on shares of Beauty Health in a research note on Friday, August 9th. Finally, Stifel Nicolaus reduced their price objective on shares of Beauty Health from $4.00 to $2.00 and set a “hold” rating on the stock in a research note on Friday, July 26th.

Insider Transactions at Beauty Health

In other Beauty Health news, Chairman Brent L. Saunders acquired 40,450 shares of the firm’s stock in a transaction that occurred on Monday, August 12th. The stock was acquired at an average cost of $1.08 per share, for a total transaction of $43,686.00. Following the transaction, the chairman now owns 5,921,769 shares of the company’s stock, valued at $6,395,510.52. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 41.00% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Beauty Health

A number of hedge funds and other institutional investors have recently made changes to their positions in SKIN. SG Americas Securities LLC bought a new position in Beauty Health during the 3rd quarter worth about $37,000. Caprock Group LLC acquired a new position in shares of Beauty Health during the second quarter worth about $38,000. Sanctuary Advisors LLC bought a new position in shares of Beauty Health during the second quarter worth about $47,000. SageView Advisory Group LLC acquired a new stake in Beauty Health in the 1st quarter valued at approximately $60,000. Finally, Susquehanna Fundamental Investments LLC bought a new stake in Beauty Health in the 2nd quarter valued at approximately $105,000. 93.26% of the stock is currently owned by institutional investors and hedge funds.

Beauty Health Trading Down 1.8 %

Shares of NASDAQ SKIN opened at $1.67 on Thursday. The company’s 50 day simple moving average is $1.58 and its 200 day simple moving average is $1.95. The company has a debt-to-equity ratio of 7.96, a current ratio of 6.49 and a quick ratio of 5.47. Beauty Health has a fifty-two week low of $0.91 and a fifty-two week high of $5.17. The firm has a market capitalization of $207.11 million, a P/E ratio of -2.01 and a beta of 0.90.

Beauty Health (NASDAQ:SKIN) last posted its quarterly earnings results on Thursday, August 8th. The company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.05). Beauty Health had a negative net margin of 22.86% and a negative return on equity of 4.57%. The company had revenue of $90.60 million during the quarter, compared to analyst estimates of $98.46 million. On average, analysts predict that Beauty Health will post -0.2 EPS for the current year.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.